MDX-1100 Rheumatoid Arthritis Drug Shows Promise WisdomCard™
Our Guides and Physician Review team have organized the Top 10 Health Resources on MDX-1100 Rheumatoid Arthritis Drug Shows Promise and compiled helpful research notes below.
Success!
Thanks for helping us improve this WisdomCard. We'll let you know if your resource makes the Top 10!.
Have another great resource to share? Go ahead and nominate another resource!
Nominate a Resource for this WisdomCard™
We have 5 top resources but need 5 more. Are there additional great resources about MDX-1100 Rheumatoid Arthritis Drug Shows Promise that we should add here? The OrganizedWisdom team looks forward to reviewing your nomination!
Research Notes on MDX-1100 Rheumatoid Arthritis Drug Shows Promise
MDX-1100, a new rheumatoid arthritis therapy using human antibodies, has shown promise while used in combination with methotrexate a common rheumatoid arthritis medication.1 Patients showed a 20 percent improvement of their rheumatoid arthritis symptoms at 12 weeks which met the primary objective of Medarex's study.1 The next step in the clinical trial involves collecting data on the physiological action of MDX-1100.1 Medarex, the company who produces MDX-1100, stressed the significance of the findings and its implications on future treatment of rheumatoid arthritis.
Fast Facts:
- According to the American College of Rheumatology, approximately 1.3 million Americans have been diagnosed with rheumatoid arthritis.2
- Methotrexate has been used since 1988 to treat rheumatoid arthritis.3
- MDX-1100 is also being investigated for treatment of other inflammatory diseases including ulcerative colitis.1
There's more WisdomCard content below this ad.
Advertisement
Latest Headlines on MDX-1100 Rheumatoid Arthritis Drug Shows Promise
Research Notes References
- ↑ 1.0 1.1 1.2 1.3 PR Newswire (via Drugs.com): Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis (May 14, 2009)
- ↑ American College of Rheumatology: Patient Education- Rheumatoid Arthritis
- ↑ American College of Rheumatology: Patient Education- Methotrexate
About this WisdomCard
- Contributor: Jacob Wolf
- Reviewer: Nicole Kinsey
- Supervised by: The OrganizedWisdom Physician Review Team
- Last update: Nov. 11, 2009
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic. In addition to filtering out spam and bad links, WisdomCards highlight tips and warnings, such as:
- Guide Favorite
- Guide Warning
- Scroll down to reach relevant content
- Video
- In Memoriam
Help improve this WisdomCard by suggesting great links.
Advertisement
Are You Depressed?
1. Have you been feeling blue, or "down in the dumps"?
About WisdomCard
Meet our contributors and reviewers
- Contributor: Jacob Wolf
- Reviewer: Nicole Kinsey
- Supervised by: The OrganizedWisdom Physician Review Team
- Redirects: MDX-1100 for RA, MDX-1100 Shows Promise for Rheumatoid Arthritis
- Last update: Nov. 11, 2009
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic by filtering out spam and bad links.
